Armstrong, Andrew J <br/><br/>
A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2007 
 - 6396-403 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-07-1036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Docetaxel<br/>Female<br/>Humans<br/>Kinetics<br/>Male<br/>Mitoxantrone--administration & dosage<br/>Neoplasm Metastasis<br/>Nomograms<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Proportional Hazards Models<br/>Prostate-Specific Antigen--metabolism<br/>Prostatic Neoplasms--diagnosis<br/>Regression Analysis<br/>Survival Analysis<br/>Taxoids--administration & dosage<br/>Treatment Outcome